ADAGE CAPITAL PARTNERS GP, L.L.C. - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 55 filers reported holding PROQR THRAPEUTICS N V in Q1 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.

Quarter-by-quarter ownership
ADAGE CAPITAL PARTNERS GP, L.L.C. ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2023$4,713,107
-19.8%
3,625,4670.0%0.01%
-15.4%
Q2 2023$5,873,257
-23.9%
3,625,4670.0%0.01%
-23.5%
Q1 2023$7,722,245
-42.4%
3,625,4670.0%0.02%
-46.9%
Q4 2022$13,414,228
+446.4%
3,625,467
+9.9%
0.03%
+433.3%
Q3 2022$2,455,000
-4.3%
3,300,0000.0%0.01%0.0%
Q2 2022$2,566,000
-14.1%
3,300,0000.0%0.01%0.0%
Q1 2022$2,987,000
-92.1%
3,300,000
-30.0%
0.01%
-91.2%
Q4 2021$37,768,000
-4.3%
4,715,1520.0%0.07%
-12.8%
Q3 2021$39,466,000
+24.7%
4,715,152
+0.4%
0.08%
+25.8%
Q2 2021$31,641,000
+2.0%
4,694,4650.0%0.06%
-1.6%
Q1 2021$31,030,000
+62.4%
4,694,465
+3.2%
0.06%
+50.0%
Q4 2020$19,110,000
-12.3%
4,550,0620.0%0.04%
-23.6%
Q3 2020$21,795,000
-21.2%
4,550,0620.0%0.06%
-22.5%
Q2 2020$27,664,000
+10.7%
4,550,0620.0%0.07%
-5.3%
Q1 2020$24,980,000
-44.9%
4,550,062
-0.5%
0.08%
-32.4%
Q4 2019$45,302,000
+110.5%
4,571,319
+22.4%
0.11%
+109.4%
Q3 2019$21,517,000
-36.7%
3,735,5070.0%0.05%
-37.6%
Q2 2019$33,993,000
-34.4%
3,735,5070.0%0.08%
-34.6%
Q1 2019$51,811,000
-12.1%
3,735,5070.0%0.13%
-20.2%
Q4 2018$58,946,000
-12.0%
3,735,507
+7.9%
0.16%
+9.4%
Q3 2018$66,989,000
+324.4%
3,461,941
+60.1%
0.15%
+313.9%
Q2 2018$15,786,000
+242.2%
2,162,527
+44.2%
0.04%
+227.3%
Q1 2018$4,613,000
+43.0%
1,500,000
+50.0%
0.01%
+57.1%
Q4 2017$3,225,0001,000,0000.01%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q1 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,237,400$5,197,0001.55%
Prosight Management, LP 255,000$1,071,0000.50%
RTW INVESTMENTS, LP 5,009,768$21,041,0000.35%
Kerrisdale Advisers, LLC 453,182$1,903,0000.15%
Artal Group S.A. 1,196,218$5,024,0000.11%
COWEN AND COMPANY, LLC 285,696$1,200,0000.11%
Golden Green, Inc. 16,999$71,0000.07%
APOGEM CAPITAL LLC 15,855$67,0000.04%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4,550,062$19,110,0000.04%
ALTRINSIC GLOBAL ADVISORS LLC 241,360$1,014,0000.03%
View complete list of PROQR THRAPEUTICS N V shareholders